hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Cortisporin]
- RxCUI
- 206511
- RxNorm name
- hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Cortisporin]
- Display name
- CORTISPORIN (Otic)
- Full name
- hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Solution [Cortisporin]
- Term type
- SBD
- Status
- Active
- Strength
- 10-3.5-10,000 var units
- Dose form
- Sol
- Route
- Otic
- Updated
- 2026-11-19 15:43:47
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
RxNav current and historical NDC rows page 1 of 1 · 14 matching rows.
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 61570003410 | rxnav_ndcs | yes |
| 00081019992 | rxnav_historical | |
| 00173019992 | rxnav_historical | |
| 16590006210 | rxnav_historical | |
| 35356051710 | rxnav_historical | |
| 52959116000 | rxnav_historical | |
| 54569089000 | rxnav_historical | |
| 54868021301 | rxnav_historical | |
| 55887076575 | rxnav_historical | |
| 58016601700 | rxnav_historical | |
| 63552019810 | rxnav_historical | |
| 63552019892 | rxnav_historical | |
| 63552019910 | rxnav_historical | |
| 63552019992 | rxnav_historical | |
UNII Substances#
UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.
No records found.
Recently Linked DailyMed Labels#
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | S01AA | Antibiotics | ATC1-4 | | polymyxin B |
| ATC | A07AA | Antibiotics | ATC1-4 | | polymyxin B |
| ATC | S01AA | Antibiotics | ATC1-4 | | neomycin |
| ATC | R02AB | Antibiotics | ATC1-4 | | neomycin |
| ATC | A07AA | Antibiotics | ATC1-4 | | neomycin |
| ATC | S03AA | Antiinfectives | ATC1-4 | | neomycin |
| ATC | S02AA | Antiinfectives | ATC1-4 | | neomycin |
| ATC | B05CA | Antiinfectives | ATC1-4 | | neomycin |
| ATC | S02AA | Antiinfectives | ATC1-4 | | polymyxin B |
| ATC | S03AA | Antiinfectives | ATC1-4 | | polymyxin B |
| ATC | A01AB | Antiinfectives and antiseptics for local oral treatment | ATC1-4 | | neomycin |
| ATC | C05AA | Corticosteroids | ATC1-4 | | hydrocortisone |
| ATC | S02BA | Corticosteroids | ATC1-4 | | hydrocortisone |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | | hydrocortisone |
| ATC | A01AC | Corticosteroids for local oral treatment | ATC1-4 | | hydrocortisone |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | | hydrocortisone |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | | hydrocortisone |
| ATC | D07XA | Corticosteroids, weak, other combinations | ATC1-4 | | hydrocortisone |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | | hydrocortisone |
| ATC | H02AB | Glucocorticoids | ATC1-4 | | hydrocortisone |
| ATC | J01GB | Other aminoglycosides | ATC1-4 | | neomycin |
| ATC | D06AX | Other antibiotics for topical use | ATC1-4 | | neomycin |
| ATC | J01XB | Polymyxins | ATC1-4 | | polymyxin B |
| FDASPL | N0000175477 | Aminoglycoside Antibacterial | EPC | has_epc | neomycin |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | hydrocortisone |
| FDASPL | N0000175499 | Polymyxin-class Antibacterial | EPC | has_epc | polymyxin B |
| MEDRT | D006854 | Hydrocortisone | CHEM | has_ingredient | hydrocortisone |
| MEDRT | D009355 | Neomycin | CHEM | has_ingredient | neomycin |
| MEDRT | D011112 | Polymyxin B | CHEM | has_ingredient | polymyxin B |
| MEDRT | D000312 | Adrenal Hyperplasia, Congenital | DISEASE | may_treat | hydrocortisone |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | hydrocortisone |
| MEDRT | D016470 | Bacteremia | DISEASE | may_treat | polymyxin B |
| MEDRT | D001424 | Bacterial Infections | DISEASE | may_prevent | neomycin |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003877 | Dermatitis, Contact | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | hydrocortisone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | polymyxin B |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydrocortisone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | neomycin |
| MEDRT | D004927 | Escherichia coli Infections | DISEASE | may_treat | polymyxin B |
| MEDRT | D004927 | Escherichia coli Infections | DISEASE | may_treat | neomycin |
| MEDRT | D015818 | Eye Infections, Bacterial | DISEASE | may_treat | polymyxin B |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D005767 | Gastrointestinal Diseases | DISEASE | may_treat | polymyxin B |
| MEDRT | D006192 | Haemophilus Infections | DISEASE | may_treat | polymyxin B |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | hydrocortisone |
| MEDRT | D006501 | Hepatic Encephalopathy | DISEASE | may_treat | neomycin |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | hydrocortisone |
| MEDRT | D015212 | Inflammatory Bowel Diseases | DISEASE | ci_with | neomycin |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | neomycin |
| MEDRT | D007710 | Klebsiella Infections | DISEASE | may_treat | polymyxin B |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D016920 | Meningitis, Bacterial | DISEASE | may_treat | polymyxin B |
| MEDRT | D010032 | Otitis Externa | DISEASE | may_treat | polymyxin B |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | hydrocortisone |
| MEDRT | D011552 | Pseudomonas Infections | DISEASE | may_treat | polymyxin B |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012769 | Shock | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012871 | Skin Diseases | DISEASE | may_treat | polymyxin B |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | neomycin |
| MEDRT | D012876 | Skin Diseases, Parasitic | DISEASE | ci_with | hydrocortisone |
| MEDRT | D017193 | Skin Diseases, Viral | DISEASE | ci_with | hydrocortisone |
| MEDRT | D018461 | Soft Tissue Infections | DISEASE | may_treat | polymyxin B |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | may_treat | hydrocortisone |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | hydrocortisone |
| MEDRT | D001745 | Urinary Bladder Diseases | DISEASE | may_treat | polymyxin B |
| MEDRT | D014947 | Wounds and Injuries | DISEASE | may_treat | polymyxin B |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | polymyxin B |
| MEDRT | N0000000227 | Cholinergic Nicotinic Antagonists | MOA | ci_moa | polymyxin B |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | hydrocortisone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | hydrocortisone |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | neomycin |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | hydrocortisone |
| MEDRT | N0000008346 | Cellular Structure Alteration | PE | has_pe | polymyxin B |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | hydrocortisone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | hydrocortisone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | hydrocortisone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | hydrocortisone |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | hydrocortisone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | hydrocortisone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | neomycin |
| MEDRT | N0000008953 | Decreased Striated Muscle Contraction | PE | ci_pe | polymyxin B |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | hydrocortisone |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 10 MG/ML / 3.5 MG/ML / 10000 UNT/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | CORTISPORIN 0.35 % / 10,000 UNT/ML / 1 % Otic Solution |
| SOURCES | Source | Gold Standard Alchemy |